Literature DB >> 7106845

Differential sensitivity of lymphocyte subsets to corticosteroid treatment.

P Rogers, A Matossian-Rogers.   

Abstract

Corticosteroid treatment of SJL mice produced a marked decrease in the number of viable lymphocytes obtained 48 hr later from the thymus, spleen and lymph node but no change in peripheral blood. Within the residual lymphocyte population there was a fall in the relative number of splenic B cells with increasing dose; in contrast the proportion of B cells increased in the lymph nodes. The most marked change however was a dose-related increase inthe Lyt-2+ population in all of the lymphoid organs examined including the thymus though, in this organ alone, the lowest dose caused a pronounced reduction in the Lyt-2+ population, since most immature thymocytes are Lyt-2+. These findings support the concept that mature thymocytes have phenotypic identity with peripheral T cells and provide a basis for the immunosuppressive action of corticosteroids.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7106845      PMCID: PMC1555489     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  Corticosteroids and immunoglobulin synthesis.

Authors:  W T Butler
Journal:  Transplant Proc       Date:  1975-03       Impact factor: 1.066

2.  Thymus-derived lymphocytes sequestered in the bone marrow of hydrocortisone-treated mice.

Authors:  J J Cohen
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

3.  Thymus-derived lymphocytes and hydrocortisone: identification of subsets of theta-bearing cells and redistribution to bone marrow.

Authors:  J W Moorhead; H N Claman
Journal:  Cell Immunol       Date:  1972-09       Impact factor: 4.868

4.  Corticosteroids and lymphoid cells.

Authors:  H N Claman
Journal:  N Engl J Med       Date:  1972-08-24       Impact factor: 91.245

5.  Mechanisms of corticosteroid action on lymphocyte subpopulations. I. Redistribution of circulating T and b lymphocytes to the bone marrow.

Authors:  A S Fauci
Journal:  Immunology       Date:  1975-04       Impact factor: 7.397

6.  Glucocorticoids and cellular immunity in vitro. Facilitation of the sensitization phase and inhibition of the effector phase of a lymphocyte anti-fibroblast reaction.

Authors:  I R Cohen; L Stavy; M Feldman
Journal:  J Exp Med       Date:  1970-12-01       Impact factor: 14.307

7.  Genetic control of specific immune suppression. I. Experimental conditions for the stimulation of suppressor cells by the copolymer L-glutamic acid50-L-tyrosine50 (GT) in nonresponder BALB/c mice.

Authors:  P Debré; J A Kapp; B Benacerraf
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

8.  Cell surface glycoproteins of murine cytotoxic T lymphocytes. I. T 145, a new cell surface glycoprotein selectively expressed on Ly 1-2+ cytotoxic T lymphocytes.

Authors:  A K Kimura; H Wigzell
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

9.  Thymus cell maturation. Studies on the origin of cortisone-resistant thymic lymphocytes.

Authors:  I L Weissman
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

10.  T-cell regulation of antibody responses: demonstration of allotype-specific helper T cells and their specific removal by suppressor T cells.

Authors:  L A Herzenberg; K Okumura; H Cantor; V L Sato; F W Shen; E A Boyse; L A Herzenberg
Journal:  J Exp Med       Date:  1976-08-01       Impact factor: 14.307

View more
  2 in total

1.  Experimental central nervous system phaeohyphomycosis following intranasal inoculation of Xylohypha bantiana in cortisone-treated mice.

Authors:  D M Dixon; W G Merz; H L Elliott; S Macleay
Journal:  Mycopathologia       Date:  1987-12       Impact factor: 2.574

2.  Modulation and biological effects of Ly-6.2 expression on EL4 tumour cells.

Authors:  A Matossian-Rogers; P D Rogers
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.